跳至主要内容
临床试验/JPRN-UMIN000018376
JPRN-UMIN000018376已完成未知

Efficacy and safety of rituximab for patients with severe rheumatic disease - Efficacy and safety of rituximab for patients with severe rheumatic disease

Yokohama City University Hospital Department of Pediatrics0 个研究点目标入组 20 人开始时间: 2015年7月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pulmonary tuberculosis, active bacterial infection or deep mycotic infection 2. Infection of HIV, HCV or HBV 3. Administraion of live vaccine within 4 weeks 4. Interstatial lung disease 5. Cardiac dysfunction 6. Pregnant subjects or subjects who do not agree with contraception during the study period

研究者

发起方
Yokohama City University Hospital Department of Pediatrics

相似试验

Efficacy and safety of rituximab for patients with... | 临床试验